Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Raymond James Downgrades Acadia Healthcare Co to Outperform, Lowers Price Target to $26

Author: Benzinga Newsdesk | August 14, 2025 06:36am
Raymond James analyst John Ransom downgrades Acadia Healthcare Co (NASDAQ:ACHC) from Strong Buy to Outperform and lowers the price target from $40 to $26.

Posted In: ACHC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist